KEY FEATURES
Full Name | Claudin 5 |
---|---|
Synonym | CLDN5;AWAL;BEC1;CPETRL1;TMVCF; |
Assay Type | Sandwich |
Reactivity | Human |
Range | 0.16-10ng/mL |
Sensitivity | 0.1ng/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human CLDN5 in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CLDN5. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CLDN5 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CLDN5, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CLDN5. You can calculate the concentration of Human CLDN5 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CLDN5 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 0.51 | 1.47 | 4.73 | 0.49 | 1.57 | 5.02 |
Standard deviation | 0.03 | 0.09 | 0.19 | 0.03 | 0.09 | 0.16 |
CV(%) | 6.79 | 5.86 | 4.11 | 5.14 | 5.93 | 3.1 |
RECOVERY
The recovery of Human CLDN5 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 95-106 | 100 |
EDTA plasma (n=8) | 94-107 | 100 |
Cell culture media (n=8) | 94-110 | 101 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CLDN5 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CLDN5 ELISA Kits
OCLN ELISA Kit | publications with CLDN5 and OCLN |
TJP1 ELISA Kit | publications with CLDN5 and TJP1 |
CLDN1 ELISA Kit | publications with CLDN5 and CLDN1 |
CLDN3 ELISA Kit | publications with CLDN5 and CLDN3 |
VEGFA ELISA Kit | publications with CLDN5 and VEGFA |
TJP2 ELISA Kit | publications with CLDN5 and TJP2 |
ESAM ELISA Kit | publications with CLDN5 and ESAM |
TJP3 ELISA Kit | publications with CLDN5 and TJP3 |
MPDZ ELISA Kit | publications with CLDN5 and MPDZ |
Pathways associated with CLDN5 ELISA Kit
Cell Adhesion Molecules (CAMs) Pathway | Cell Adhesion Molecules (CAMs) Pathway |
Cell Junction Organization Pathway | Cell Junction Organization Pathway |
Cell-Cell Communication Pathway | Cell-Cell Communication Pathway |
Cell-cell Junction Organization Pathway | Cell-cell Junction Organization Pathway |
Diurnally Regulated Genes With Circadian Orthologs Pathway | Diurnally Regulated Genes With Circadian Orthologs Pathway |
Hepatitis C Pathway | Hepatitis C Pathway |
Leukocyte Transendothelial Migration Pathway | Leukocyte Transendothelial Migration Pathway |
Diseases associated with CLDN5 ELISA Kit
Nervous System Diseases | publications with CLDN5 and Nervous System Diseases |
Cardiovascular Diseases | publications with CLDN5 and Cardiovascular Diseases |
Edema | publications with CLDN5 and Edema |
Inflammation | publications with CLDN5 and Inflammation |
Necrosis | publications with CLDN5 and Necrosis |
Adenocarcinoma | publications with CLDN5 and Adenocarcinoma |
Breast Neoplasms | publications with CLDN5 and Breast Neoplasms |
Heart Diseases | publications with CLDN5 and Heart Diseases |
Neoplasm Metastasis | publications with CLDN5 and Neoplasm Metastasis |
Pain | publications with CLDN5 and Pain |
Organs/Tissues associated with CLDN5 ELISA Kit
Brain | publications with CLDN5 and Brain |
Vascular | publications with CLDN5 and Vascular |
Nerve | publications with CLDN5 and Nerve |
Eye | publications with CLDN5 and Eye |
Lung | publications with CLDN5 and Lung |
Embryonic Tissue | publications with CLDN5 and Embryonic Tissue |
Intestine | publications with CLDN5 and Intestine |
Heart | publications with CLDN5 and Heart |
Muscle | publications with CLDN5 and Muscle |
Skin | publications with CLDN5 and Skin |